These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 17033827
1. Interactions of human tenascin-X domains with dermal extracellular matrix molecules. Egging D, van den Berkmortel F, Taylor G, Bristow J, Schalkwijk J. Arch Dermatol Res; 2007 Jan; 298(8):389-96. PubMed ID: 17033827 [Abstract] [Full Text] [Related]
2. Dermal connective tissue development in mice: an essential role for tenascin-X. Egging DF, van Vlijmen I, Starcher B, Gijsen Y, Zweers MC, Blankevoort L, Bristow J, Schalkwijk J. Cell Tissue Res; 2006 Mar; 323(3):465-74. PubMed ID: 16331473 [Abstract] [Full Text] [Related]
3. Elastic fiber abnormalities in hypermobility type Ehlers-Danlos syndrome patients with tenascin-X mutations. Zweers MC, Dean WB, van Kuppevelt TH, Bristow J, Schalkwijk J. Clin Genet; 2005 Apr; 67(4):330-4. PubMed ID: 15733269 [Abstract] [Full Text] [Related]
4. Tenascin-X, collagen, elastin, and the Ehlers-Danlos syndrome. Bristow J, Carey W, Egging D, Schalkwijk J. Am J Med Genet C Semin Med Genet; 2005 Nov 15; 139C(1):24-30. PubMed ID: 16278880 [Abstract] [Full Text] [Related]
5. Wound healing in tenascin-X deficient mice suggests that tenascin-X is involved in matrix maturation rather than matrix deposition. Egging D, van Vlijmen-Willems I, van Tongeren T, Schalkwijk J, Peeters A. Connect Tissue Res; 2007 Nov 15; 48(2):93-8. PubMed ID: 17453911 [Abstract] [Full Text] [Related]
6. A model of tenascin-X integration within the collagenous network. Lethias C, Carisey A, Comte J, Cluzel C, Exposito JY. FEBS Lett; 2006 Nov 13; 580(26):6281-5. PubMed ID: 17078949 [Abstract] [Full Text] [Related]
7. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Burch GH, Gong Y, Liu W, Dettman RW, Curry CJ, Smith L, Miller WL, Bristow J. Nat Genet; 1997 Sep 13; 17(1):104-8. PubMed ID: 9288108 [Abstract] [Full Text] [Related]
8. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. Schalkwijk J, Zweers MC, Steijlen PM, Dean WB, Taylor G, van Vlijmen IM, van Haren B, Miller WL, Bristow J. N Engl J Med; 2001 Oct 18; 345(16):1167-75. PubMed ID: 11642233 [Abstract] [Full Text] [Related]
9. Modulation of collagen fibrillogenesis by tenascin-X and type VI collagen. Minamitani T, Ikuta T, Saito Y, Takebe G, Sato M, Sawa H, Nishimura T, Nakamura F, Takahashi K, Ariga H, Matsumoto K. Exp Cell Res; 2004 Aug 01; 298(1):305-15. PubMed ID: 15242785 [Abstract] [Full Text] [Related]
10. Transplantation of reconstructed human skin on nude mice: a model system to study expression of human tenascin-X and elastic fiber components. Zweers MC, Schalkwijk J, van Kuppevelt TH, van Vlijmen-Willems IM, Bergers M, Lethias C, Lamme EN. Cell Tissue Res; 2005 Feb 01; 319(2):279-87. PubMed ID: 15558324 [Abstract] [Full Text] [Related]
11. Deficiency of tenascin-X causes a decrease in the level of expression of type VI collagen. Minamitani T, Ariga H, Matsumoto K. Exp Cell Res; 2004 Jul 01; 297(1):49-60. PubMed ID: 15194424 [Abstract] [Full Text] [Related]
12. Mild muscular features in tenascin-X knockout mice, a model of Ehlers-danlos syndrome. Voermans NC, Verrijp K, Eshuis L, Balemans MC, Egging D, Sterrenburg E, van Rooij IA, van der Laak JA, Schalkwijk J, van der Maarel SM, Lammens M, van Engelen BG. Connect Tissue Res; 2011 Oct 01; 52(5):422-32. PubMed ID: 21405982 [Abstract] [Full Text] [Related]
13. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Mao JR, Taylor G, Dean WB, Wagner DR, Afzal V, Lotz JC, Rubin EM, Bristow J. Nat Genet; 2002 Apr 01; 30(4):421-5. PubMed ID: 11925569 [Abstract] [Full Text] [Related]
14. Tenascin-X increases the stiffness of collagen gels without affecting fibrillogenesis. Margaron Y, Bostan L, Exposito JY, Malbouyres M, Trunfio-Sfarghiu AM, Berthier Y, Lethias C. Biophys Chem; 2010 Mar 01; 147(1-2):87-91. PubMed ID: 20089348 [Abstract] [Full Text] [Related]
15. Muscle characteristics and altered myofascial force transmission in tenascin-X-deficient mice, a mouse model of Ehlers-Danlos syndrome. Huijing PA, Voermans NC, Baan GC, Busé TE, van Engelen BG, de Haan A. J Appl Physiol (1985); 2010 Oct 01; 109(4):986-95. PubMed ID: 20576846 [Abstract] [Full Text] [Related]
16. Analysis of obstetric complications and uterine connective tissue in tenascin-X-deficient humans and mice. Egging DF, van Vlijmen-Willems I, Choi J, Peeters AC, van Rens D, Veit G, Koch M, Davis EC, Schalkwijk J. Cell Tissue Res; 2008 Jun 01; 332(3):523-32. PubMed ID: 18335242 [Abstract] [Full Text] [Related]
17. [The Ehlers-Danlos syndrome: the extracellular matrix scaffold in question]. Fichard A, Chanut-Delalande H, Ruggiero F. Med Sci (Paris); 2003 Apr 01; 19(4):443-52. PubMed ID: 12836217 [Abstract] [Full Text] [Related]
18. A novel role for the extracellular matrix glycoprotein-Tenascin-X in gastric function. Aktar R, Peiris M, Fikree A, Eaton S, Kritas S, Kentish SJ, Araujo EJA, Bacarin C, Page AJ, Voermans NC, Aziz Q, Blackshaw LA. J Physiol; 2019 Mar 01; 597(6):1503-1515. PubMed ID: 30605228 [Abstract] [Full Text] [Related]
19. Titin-based stiffening of muscle fibers in Ehlers-Danlos Syndrome. Ottenheijm CA, Voermans NC, Hudson BD, Irving T, Stienen GJ, van Engelen BG, Granzier H. J Appl Physiol (1985); 2012 Apr 01; 112(7):1157-65. PubMed ID: 22223454 [Abstract] [Full Text] [Related]
20. Homozygous Gly530Ser substitution in COL5A1 causes mild classical Ehlers-Danlos syndrome. Giunta C, Nuytinck L, Raghunath M, Hausser I, De Paepe A, Steinmann B. Am J Med Genet; 2002 May 15; 109(4):284-90. PubMed ID: 11992482 [Abstract] [Full Text] [Related] Page: [Next] [New Search]